| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 134, 70-77, Copyright © 1994 by Endocrine Society
ARTICLES |
JL Gu, R Natarajan, J Ben-Ezra, G Valente, S Scott, T Yoshimoto, S Yamamoto, JJ Rossi and JL Nadler
Department of Diabetes, Endocrinology, and Metabolism, City of Hope National Medical Center, Duarte, California 91010.
The 12-lipoxygenase (LO) pathway of arachidonic acid plays an important role in angiotensin II (AII)-mediated aldosterone synthesis. Several distinct isoforms of 12-LO have been cloned. However, in humans only the platelet form of 12-LO has been reported to be present. Western immunoblotting analysis in cultured human adrenal glomerulosa cells using polyclonal antibodies to porcine leukocyte 12-LO enzyme or peptide showed a specific 72-kilodalton band, which is identical to the molecular size of the porcine leukocyte form of 12-LO. In addition, AII (10(-7)) increased the intensity of the 72-kilodalton band nearly 2- fold over basal. In situ hybridization analysis indicated a strong positive reaction with the porcine leukocyte type of 12-LO antisense riboprobe in the zona glomerulosa of the adrenal cortex. The 12-LO probe also recognized a near 4-kilobase messenger RNA (mRNA) from human glomerulosa cells in Northern blots. Since the leukocyte type of 12-LO is highly homologous to human 15-LO, a reverse transcriptase and polymerase chain reaction was used to analyze the specific type of 12- LO mRNA in human cells. The mRNA for a porcine leukocyte type of 12-LO was detected in human adrenal glomerulosa cells, and the level of 12-LO transcripts was increased approximately 60-fold by AII (10(-7) M). The leukocyte type of 12-LO also was detected in human monocyte-like U937 cells, but not in IM-9 lymphocytes or human erythroleukemia cells. These results suggest that human adrenal glomerulosa cells and human monocyte-like U937 cells express a 12-LO which has immunological and molecular biological characteristics similar to the porcine leukocyte 12-LO.
This article has been cited by other articles:
![]() |
H. Yuan, L. Lanting, Z.-G. Xu, S.-L. Li, P. Swiderski, S. Putta, M. Jonnalagadda, M. Kato, and R. Natarajan Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes Am J Physiol Renal Physiol, August 1, 2008; 295(2): F605 - F617. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gu, Y. Wen, A. Mison, and J. L. Nadler 12-Lipoxygenase Pathway Increases Aldosterone Production, 3',5'-Cyclic Adenosine Monophosphate Response Element-Binding Protein Phosphorylation, and p38 Mitogen-Activated Protein Kinase Activation in H295R Human Adrenocortical Cells Endocrinology, February 1, 2003; 144(2): 534 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Reddy, S. G. Adler, Y.-S. Kim, L. Lanting, J. Rossi, S.-W. Kang, J. L. Nadler, A. Shahed, and R. Natarajan Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells Am J Physiol Renal Physiol, November 1, 2002; 283(5): F985 - F994. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Reddy, P.-R. Thimmalapura, L. Lanting, J. L. Nadler, S. Fatima, and R. Natarajan The Oxidized Lipid and Lipoxygenase Product 12(S)-Hydroxyeicosatetraenoic Acid Induces Hypertrophy and Fibronectin Transcription in Vascular Smooth Muscle Cells via p38 MAPK and cAMP Response Element-binding Protein Activation. MEDIATION OF ANGIOTENSIN II EFFECTS J. Biol. Chem., March 15, 2002; 277(12): 9920 - 9928. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Limor, G. Weisinger, S. Gilad, E. Knoll, O. Sharon, A. Jaffe, F. Kohen, E. Berger, B. Lifschizt-Mercer, and N. Stern A Novel Form of Platelet-Type 12-Lipoxygenase mRNA in Human Vascular Smooth Muscle Cells Hypertension, October 1, 2001; 38(4): 864 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wen, J. Gu, Y. Liu, P. H. Wang, Y. Sun, and J. L. Nadler Overexpression of 12-Lipoxygenase Causes Cardiac Fibroblast Cell Growth Circ. Res., January 19, 2001; 88(1): 70 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kawajiri, D. Zhuang, N. Qiao, T. Yoshimoto, M. Yamamoto, S. Iseki, and K. Hamaguchi Expression of Arachidonate 12-Lipoxygenase in Rat Tissues: A Possible Role in Glucagon Secretion J. Histochem. Cytochem., October 1, 2000; 48(10): 1411 - 1420. [Abstract] [Full Text] |
||||
![]() |
R. Natarajan, H. Pei, J.-L. Gu, J. M. Sarma, and J. Nadler Evidence for 12-lipoxygenase induction in the vessel wall following balloon injury Cardiovasc Res, February 1, 1999; 41(2): 489 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Natarajan, J. Rosdahl, N. Gonzales, and W. Bai Regulation of 12-Lipoxygenase by Cytokines in Vascular Smooth Muscle Cells Hypertension, October 1, 1997; 30(4): 873 - 879. [Abstract] [Full Text] |
||||
![]() |
R. Natarajan, R. Esworthy, W. Bai, J.-L. Gu, S. Wilczynski, and J. Nadler Increased 12-Lipoxygenase Expression in Breast Cancer Tissues and Cells. Regulation by Epidermal Growth Factor J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1790 - 1798. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Kisch, A. Jaffe, E. Knoll, and N. Stern Role of the Lipoxygenase Pathway in Angiotensin II–Induced Vasoconstriction in the Human Placenta Hypertension, March 1, 1997; 29(3): 796 - 801. [Abstract] [Full Text] |
||||
![]() |
J. A. Kim, J.-L. Gu, R. Natarajan, J. A. Berliner, and J. L. Nadler A Leukocyte Type of 12-Lipoxygenase Is Expressed in Human Vascular and Mononuclear Cells : Evidence for Upregulation by Angiotensin II Arterioscler Thromb Vasc Biol, July 1, 1995; 15(7): 942 - 948. [Abstract] [Full Text] |
||||
![]() |
J.-L. Gu, D. Veerapanane, J. Rossi, R. Natarajan, L. Thomas, and J. Nadler Ribozyme-Mediated Inhibition of Expression of Leukocyte-type 12-Lipoxygenase in Porcine Aortic Vascular Smooth Muscle Cells Circ. Res., July 1, 1995; 77(1): 14 - 20. [Abstract] [Full Text] |
||||
![]() |
S. Ravalli, C. C. Marboe, V. D. D'Agati, R. E. Michler, E. Sigal, and P. J. Cannon Immunohistochemical Demonstration of 15-Lipoxygenase in Transplant Coronary Artery Disease Arterioscler Thromb Vasc Biol, March 1, 1995; 15(3): 340 - 348. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |